Daniel E. Geffken - 26 Oct 2023 Form 4 Insider Report for ProMIS Neurosciences Inc. (PMN)

Role
Chief Financial Officer
Signature
/s/ Max A. Milbury Attorney-in-Fact for Daniel E. Geffken
Issuer symbol
PMN
Transactions as of
26 Oct 2023
Transactions value $
$0
Form type
4
Filing time
30 Oct 2023, 19:42:08
Previous filing
29 Aug 2023
Next filing
16 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMN Option (right to buy) Award $0 +2.5K $0.00 2.5K 26 Oct 2023 Common Shares 2.5K $1.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to this option shall vest on October 26, 2024, and the balance shall vest ratably over 36 months.